Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49. https://doi.org/10.3322/caac.21660.
Article CAS PubMed Google Scholar
Shiina S, Tateishi R, Arano T, Uchino K, Enooku K, Nakagawa H, et al. Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors. Am J Gastroenterol. 2012;107:569–77. https://doi.org/10.1038/ajg.2011.425.
Article CAS PubMed Google Scholar
Tateishi R, Shiina S, Teratani T, Obi S, Sato S, Koike Y, et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma: an analysis of 1000 cases. Cancer. 2005;103:1201–9. https://doi.org/10.1002/cncr.20892.
Lee DH, Lee JM, Lee JY, Kim SH, Yoon JH, Kim YJ, et al. Radiofrequency ablation of hepatocellular carcinoma as first-line treatment: long-term results and prognostic factors in 162 patients with cirrhosis. Radiology. 2014;270:900–9. https://doi.org/10.1148/radiol.13130940.
Lencioni R, Cioni D, Crocetti L, Franchini C, Pina CD, Lera J, et al. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology. 2005;234:961–7. https://doi.org/10.1148/radiol.2343040350.
Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN. Treatment of focal liver tumors with percutaneous radiofrequency ablation: complications encountered in a multicenter study. Radiology. 2003;226:441–51. https://doi.org/10.1148/radiol.2262012198.
Mulier S, Mulier P, Ni Y, Miao Y, Dupas B, Marchal G, et al. Complications of radiofrequency coagulation of liver tumours. Br J Surg. 2002;89:1206–22. https://doi.org/10.1046/j.1365-2168.2002.02168.x.
Article CAS PubMed Google Scholar
Shiina S, Sato K, Tateishi R, Shimizu M, Ohama H, Hatanaka T, et al. Percutaneous ablation for hepatocellular carcinoma: comparison of various ablation techniques and surgery. Can J Gastroenterol Hepatol. 2018;2018:4756147. https://doi.org/10.1155/2018/4756147.
Article PubMed PubMed Central Google Scholar
Lai R, Peng Z, Chen D, Wang X, Xing W, Zeng W, et al. The effects of anesthetic technique on cancer recurrence in percutaneous radiofrequency ablation of small hepatocellular carcinoma. Anesth Analg. 2012;114:290–6. https://doi.org/10.1213/ANE.0b013e318239c2e3.
Wagner HJ, Nowacki J, Klose KJ. Propofol versus midazolam for sedation during percutaneous transluminal angioplasty. J Vasc Interv Radiol. 1996;7:673–80. https://doi.org/10.1016/S1051-0443(96)70827-8.
Article CAS PubMed Google Scholar
Sato K, Taniki N, Kanazawa R, Shimizu M, Ishii S, Ohama H, et al. Efficacy and safety of deep sedation in percutaneous radiofrequency ablation for hepatocellular carcinoma. Adv Ther. 2019;36:344–54. https://doi.org/10.1007/s12325-018-0865-z.
Lundström S, Twycross R, Mihalyo M, Wilcock A. Propofol J Pain Symptom Manag. 2010;40:466–70. https://doi.org/10.1016/j.jpainsymman.2010.07.001.
McQuaid KR, Laine L. A systematic review and meta-analysis of randomized, controlled trials of moderate sedation for routine endoscopic procedures. Gastrointest Endosc. 2008;67:910–23. https://doi.org/10.1016/j.gie.2007.12.046.
DeWitt J, LeBlanc J, McHenry L, Ciaccia D, Imperiale T, Chappo J, et al. Endoscopic ultrasound-guided fine needle aspiration cytology of solid liver lesions: a large single-center experience. Am J Gastroenterol. 2003;98:1976–81. https://doi.org/10.1111/j.1572-0241.2003.07638.x.
Jung M, Hofmann C, Kiesslich R, Brackertz A. Improved sedation in diagnostic and therapeutic ERCP: propofol is an alternative to midazolam. Endoscopy. 2000;32:233–8. https://doi.org/10.1055/s-2000-96.
Article CAS PubMed Google Scholar
Riphaus A, Stergiou N, Wehrmann T. Sedation with propofol for routine ERCP in high-risk octogenarians: a randomized, controlled study. Am J Gastroenterol. 2005;100:1957–63. https://doi.org/10.1111/j.1572-0241.2005.41672.x.
Article CAS PubMed Google Scholar
Singh H, Poluha W, Cheung M, Choptain N, Baron KI, Taback SP. Propofol for sedation during colonoscopy. Cochrane Database Syst Rev. 2008;2008: CD006268. https://doi.org/10.1002/14651858.CD006268.pub2.
Article PubMed PubMed Central Google Scholar
Meining A, Semmler V, Kassem AM, Sander R, Frankenberger U, Burzin M, et al. The effect of sedation on the quality of upper gastrointestinal endoscopy: an investigator-blinded, randomized study comparing propofol with midazolam. Endoscopy. 2007;39:345–9. https://doi.org/10.1055/s-2006-945195.
Article CAS PubMed Google Scholar
Qadeer MA, Vargo JJ, Khandwala F, Lopez R, Zuccaro G. Propofol versus traditional sedative agents for gastrointestinal endoscopy: a meta-analysis. Clin Gastroenterol Hepatol. 2005;3:1049–56. https://doi.org/10.1016/S1542-3565(05)00742-1.
Article CAS PubMed Google Scholar
Wang D, Chen C, Chen J, Xu Y, Wang L, Zhu Z, et al. The use of propofol as a sedative agent in gastrointestinal endoscopy: a meta-analysis. PLoS ONE. 2013;8: e53311. https://doi.org/10.1371/journal.pone.0053311.
Article CAS PubMed PubMed Central Google Scholar
Puijk RS, Ziedses des Plantes VZ, Nieuwenhuizen S, Ruarus AH, Vroomen LGPH, de Jong MC, et al. Propofol compared to midazolam sedation and to general anesthesia for percutaneous microwave ablation in patients with hepatic malignancies: a single-center comparative analysis of three historical cohorts. Cardiovasc Interv Radiol. 2019;42(11):1597–608. https://doi.org/10.1007/s00270-019-02273-y.
Kanogawa N, Ogasawara S, Ooka Y, Inoue M, Wakamatsu T, Yokoyama M, et al. Propofol versus midazolam for sedation during radiofrequency ablation in patients with hepatocellular carcinoma. JGH Open. 2021;5:273–9. https://doi.org/10.1002/jgh3.12483.
Amornyotin S, Kongphlay S. Propofol-based deep sedation for percutaneous radiofrequency ablation in sick elderly patients with hepatocellular carcinoma in a developing country. JACCOA. 2017. https://doi.org/10.15406/jaccoa.2017.08.00303.
Joung KW, Choi SS, Jang DM, Kong YG, Lee HM, Shim JH, et al. Comparative effects of dexmedetomidine and propofol on US-guided radiofrequency ablation of hepatic neoplasm under monitored anesthesia care: a randomized controlled study. Medicine (Baltimore). 2015;94: e1349. https://doi.org/10.1097/MD.0000000000001349.
Article CAS PubMed Google Scholar
The Royal College of Radiologists. Sedation, analgesia and anaesthesia in the radiology department. 2nd ed. BFCR (18) 2 London: The Royal College of Radiologists, 2018 https://www.rcr.ac.uk/. Accessed 3 Sept 2022.
Vari A, Gangi A. Anesthesia practices for interventional radiology in Europe. Cardiovasc Interv Radiol. 2017;40:803–13. https://doi.org/10.1007/s00270-017-1576-6.
Dumonceau JM, Riphaus A, Schreiber F, Vilmann P, Beilenhoff U, Aparicio JR, et al. Non-anesthesiologist administration of propofol for gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy, European Society of Gastroenterology and Endoscopy Nurses and Associates Guideline-updated June 2015. Endoscopy. 2015;47:1175–89. https://doi.org/10.1055/s-0034-1393414.
Saklad M. Grading of patients for surgical procedures. Anesthesiology. 1941;2:281–4. https://doi.org/10.1097/00000542-194105000-00004.
Chung F, Yegneswaran B, Liao P, Chung SA, Vairavanathan S, Islam S, et al. STOP questionnaire: a tool to screen patients for obstructive sleep apnea. Anesthesiology. 2008;108:812–21. https://doi.org/10.1097/ALN.0b013e31816d91b5.
Aldrete JA. The post-anesthesia recovery score revisited. J Clin Anesth. 1995;7:89–91. https://doi.org/10.1016/0952-8180(94)00001-K.
Comments (0)